1st Quarter - Report

GILBERT'S LLP for MYLAN LABORATORIES INC

Firm
Client
Income
$90,000
Expenses
—

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Enforcement and possible reform of the legislation and regulations relating to drug approval

LobbyistCovered position, as disclosed
NAWEL BAILEY —
TIM GILBERT —

Contacted: SENATE; Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES

Pharmacy PHA

Enforcement and possible reform of the legislation and regulations relating to drug approval

LobbyistCovered position, as disclosed
NAWEL BAILEY —
TIM GILBERT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Federal Trade Commission (FTC)

Government Issues GOV

Enforcement and possible reform of the legislation and regulations relating to drug approval

LobbyistCovered position, as disclosed
NAWEL BAILEY —
TIM GILBERT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC)

Health Issues HCR

Enforcement and possible reform of the legislation and regulations relating to drug approval

LobbyistCovered position, as disclosed
NAWEL BAILEY —
TIM GILBERT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Federal Trade Commission (FTC)

Foreign Relations FOR

Enforcement and possible reform of the legislation and regulations relating to drug approval

LobbyistCovered position, as disclosed
NAWEL BAILEY —
TIM GILBERT —

Contacted: SENATE; Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES

Consumer Issues/Safety/Products CSP

Enforcement and possible reform of legislations and regultions relating to drug approval

LobbyistCovered position, as disclosed
NAWEL BAILEY —
TIM GILBERT —

Contacted: SENATE; Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.